Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Kaplan

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
International Journal of Colorectal Disease|February 15, 2021
The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter studyNadiye Akdeniz, Muhammet Ali Kaplan, Doğan Uncu, et al.
Contemporary Oncology (Poznan, Poland)|September 27, 2014
Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical OncologyKucukoner Mehmet, Cihan Sener, Ummugul Uyeturk, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Cancers|November 27, 2024
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and OutcomesMehmet Fatih Ozbay, Hakan Harputluoglu, Mustafa Karaca, et al.
Journal of Cancer Research and Clinical Oncology|December 3, 2013
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncologyOzge Gumusay, Ugur Coskun, Tülay Akman, et al.
Hepato-Gastroenterology|November 21, 2012
Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from TurkeyMesut Seker, Alper Sevinc, Ramazan Yildiz, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 21, 2012
Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter studyA Inal, F T Kos, E Algin, et al.
Oncology Research and Treatment|August 23, 2019
Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre StudyMuhammet Ali Kaplan, Sukru Ozaydin, Halis Yerlikaya, et al.
Acta Oncologica (Stockholm, Sweden)|April 21, 2023
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH studyAhmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, et al.
Current Medical Research and Opinion|May 29, 2024
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry studyNuri Karadurmus, Muhammet Ali Kaplan, Mehmet Ali Nahit Sendur, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
International Journal of Colorectal Disease|February 15, 2021
The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter studyNadiye Akdeniz, Muhammet Ali Kaplan, Doğan Uncu, et al.
Contemporary Oncology (Poznan, Poland)|September 27, 2014
Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical OncologyKucukoner Mehmet, Cihan Sener, Ummugul Uyeturk, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Cancers|November 27, 2024
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and OutcomesMehmet Fatih Ozbay, Hakan Harputluoglu, Mustafa Karaca, et al.
Journal of Cancer Research and Clinical Oncology|December 3, 2013
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncologyOzge Gumusay, Ugur Coskun, Tülay Akman, et al.
Hepato-Gastroenterology|November 21, 2012
Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from TurkeyMesut Seker, Alper Sevinc, Ramazan Yildiz, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 21, 2012
Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter studyA Inal, F T Kos, E Algin, et al.
Oncology Research and Treatment|August 23, 2019
Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre StudyMuhammet Ali Kaplan, Sukru Ozaydin, Halis Yerlikaya, et al.
Acta Oncologica (Stockholm, Sweden)|April 21, 2023
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH studyAhmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, et al.
Current Medical Research and Opinion|May 29, 2024
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry studyNuri Karadurmus, Muhammet Ali Kaplan, Mehmet Ali Nahit Sendur, et al.
Pageof 15